Page 300 - Drug Class Review
P. 300
Page 180 of 205
Drug Effectiveness Review Project
placebo 73 62 NR 17.7 No significant differences in MMSE scores between groups (P = 0.55) CGRS and RGRS scores significantly better in TAC compared to placebo (P = 0.012 and P =
Alzheimer classification: Mild-moderate
Groups similar at baseline: Yes
Health Outcome Measures: NR 0.013)
tacrine 76 66 NR 16.8 Primary Outcome Measures: MMSE; CGRS Secondary Outcome Measures: RGRS; GBS; ADAS-Noncog Timing of assessments: Baseline and weeks 4, 8 and 12 Intermediate Outcome Measures:
• • •
Final Report Update 1 Authors: Wood et al. Year: 1994 POPULATION CHARACTERISTICS: Mean age (years): Sex (% female): Ethnicity: Other germane population qualities: MMSE • OUTCOME ASSESSMENT: RESULTS: Alzheimer's Drugs
